Four shares that have failed to follow the market higher today are listed below. Here’s why they are tumbling lower:
The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price has fallen 2% to $27.82. Investors may believe that the prospect of a COVID19 vaccine being released in the near future will lead to a reduction in demand for this medical device company’s ventilators.
The Mesoblast limited (ASX: MSB) share price has crashed 8% lower to $3.82. This decline also appears to have been driven by the vaccine news. Mesoblast has been busy trialling its own treatment for COVID19, with promising results. If a vaccine is successful then there would arguably be little need for a treatment.
The Northern Star Resources Ltd (ASX: NST) share price is down over 3% to $14.14. Investors have been selling Northern Star and other gold miners today after a sharp pullback in the price of the precious metal. The prospect of a vaccine has given risk on assets a major boost and led to a fall in demand for safe haven assets.
The TechnologyOne Ltd (ASX: TNE) share price is down over 1.5% to $9.66. This enterprise software company’s shares were down as much as 5% following the release of its half year update. Investors appear underwhelmed by its 6% lift in sales and profits during the six months ending March 31. Especially given the significant premium of 52x trailing earnings that its shares trade at. TechnologyOne provided guidance for the full year and expects net profit before tax to increase 8% to 12% year on year.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.